Stockreport

Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026

Revolution Medicines, Inc.  (RVMD) 
PDF REDWOOD CITY, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies [Read more]